Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1986-4-25
|
| pubmed:language |
ita
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0017-0445
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
32
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
29-30
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:3913619-Aged,
pubmed-meshheading:3913619-Antibiotics, Antineoplastic,
pubmed-meshheading:3913619-Clinical Trials as Topic,
pubmed-meshheading:3913619-Daunorubicin,
pubmed-meshheading:3913619-Heart Diseases,
pubmed-meshheading:3913619-Humans,
pubmed-meshheading:3913619-Idarubicin,
pubmed-meshheading:3913619-Middle Aged,
pubmed-meshheading:3913619-Neoplasms
|
| pubmed:articleTitle |
[Evaluation of 4-demethoxydaunorubicin toxicity (IMI 30). Preliminary data].
|
| pubmed:publicationType |
Journal Article,
Clinical Trial
|